Literature DB >> 27324880

Quality of life and hernia development 5 years after open abdomen treatment with vacuum-assisted wound closure and mesh-mediated fascial traction.

U Petersson1,2, T Bjarnason3,4, M Björck5, A Montgomery3,6, P Rogmark3,6, M Svensson7, K Sörelius5, S Acosta3,8.   

Abstract

PURPOSE: To report incisional hernia (IH) incidence, abdominal wall (AW) discomfort and quality of life (QoL) 5 years after open abdomen treatment with vacuum-assisted wound closure and mesh-mediated fascial traction (VAWCM).
METHODS: Five-year follow-up of patients included in a prospective study 2006-2009. The protocol included physical examination, patient interview, chart review, questionnaires on abdominal wall and stoma complaints and the SF-36 questionnaire.
RESULTS: Fifty-five (12 women, 43 men; median age 70 years) of 111 included patients were alive. Follow-up rate was 91 %. Cumulative IH incidence during the whole study was 62 %. One-third of the IHs was repaired. At 5-year follow-up 59 % of IHs were clinically detectable. AW symptoms were equivalent in patients with (15/23) and without (11/21) IH (p = 0.541). SF-36 scores were lower than population mean for component scores and all subscales except bodily pain. Patients with major co-morbidity had lower physical component score [31.6 (95 %, CI 25.6-37.4)] compared to those without [48.9 (95 %, CI 46.2-51.4)]. Major co-morbidity was not associated with IH (p = 0.56), AW symptoms (p = 0.54) or stoma (p = 0.10). Patients with IH or other AW symptoms had similar SF-36 results compared to those without, whereas patients with a stoma had >5 point lower mean scores for general health, social function and physical component score compared to those without.
CONCLUSIONS: VAWCM treatment results in high incidence of IH. However, at five years, there was no detectable difference in abdominal wall complaints and QoL in patients with IH compared to those without. Lower QoL appeared mainly to be associated with the presence of major co-morbidity.

Entities:  

Keywords:  Incisional hernia; Mesh-mediated fascial traction; Open abdomen; Quality of life; SF-36; Vacuum-assisted wound closure

Mesh:

Year:  2016        PMID: 27324880     DOI: 10.1007/s10029-016-1516-4

Source DB:  PubMed          Journal:  Hernia        ISSN: 1248-9204            Impact factor:   4.739


  27 in total

1.  Parastomal hernia: clinical and radiological definitions.

Authors:  A Jänes; L Weisby; L A Israelsson
Journal:  Hernia       Date:  2010-12-28       Impact factor: 4.739

2.  One hundred percent fascial approximation can be achieved in the postinjury open abdomen with a sequential closure protocol.

Authors:  Clay Cothren Burlew; Ernest E Moore; Walter L Biffl; Denis D Bensard; Jeffrey L Johnson; Carlton C Barnett
Journal:  J Trauma Acute Care Surg       Date:  2012-01       Impact factor: 3.313

Review 3.  Systematic review and meta-analysis of the open abdomen and temporary abdominal closure techniques in non-trauma patients.

Authors:  J J Atema; S L Gans; M A Boermeester
Journal:  World J Surg       Date:  2015-04       Impact factor: 3.352

4.  Multicentre prospective study of fascial closure rate after open abdomen with vacuum and mesh-mediated fascial traction.

Authors:  S Acosta; T Bjarnason; U Petersson; B Pålsson; A Wanhainen; M Svensson; K Djavani; M Björck
Journal:  Br J Surg       Date:  2011-01-14       Impact factor: 6.939

5.  Prospective evaluation of vacuum-assisted fascial closure after open abdomen: planned ventral hernia rate is substantially reduced.

Authors:  Preston R Miller; J Wayne Meredith; James C Johnson; Michael C Chang
Journal:  Ann Surg       Date:  2004-05       Impact factor: 12.969

6.  Incisional hernia rate after open abdomen treatment with negative pressure and delayed primary fascia closure.

Authors:  A Brandl; E Laimer; A Perathoner; M Zitt; J Pratschke; R Kafka-Ritsch
Journal:  Hernia       Date:  2013-03-02       Impact factor: 4.739

7.  Longterm impact of abdominal decompression: a prospective comparative analysis.

Authors:  Michael L Cheatham; Karen Safcsak
Journal:  J Am Coll Surg       Date:  2008-07-21       Impact factor: 6.113

Review 8.  Current state of laparoscopic parastomal hernia repair: A meta-analysis.

Authors:  Francis J DeAsis; Brittany Lapin; Matthew E Gitelis; Michael B Ujiki
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

Review 9.  Systematic review and evidence based recommendations for the use of negative pressure wound therapy in the open abdomen.

Authors:  A Bruhin; F Ferreira; M Chariker; J Smith; N Runkel
Journal:  Int J Surg       Date:  2014-08-28       Impact factor: 6.071

10.  The prevalence of parastomal hernia after formation of an end colostomy. A new clinico-radiological classification.

Authors:  J Moreno-Matias; X Serra-Aracil; A Darnell-Martin; J Bombardo-Junca; L Mora-Lopez; M Alcantara-Moral; P Rebasa; I Ayguavives-Garnica; S Navarro-Soto
Journal:  Colorectal Dis       Date:  2008-05-03       Impact factor: 3.788

View more
  4 in total

1.  Delayed closure of open abdomen in septic patients treated with negative pressure wound therapy and dynamic fascial suture: the long-term follow-up study.

Authors:  Anna Theresa Hofmann; Simone Gruber-Blum; Michael Lechner; Alexander Petter-Puchner; Karl Glaser; René Fortelny
Journal:  Surg Endosc       Date:  2017-04-19       Impact factor: 4.584

2.  Long-term impact of incisional hernia on quality of life after colonic cancer resection.

Authors:  K K Jensen; K J Emmertsen; S Laurberg; P-M Krarup
Journal:  Hernia       Date:  2019-05-24       Impact factor: 4.739

3.  Intensive care and health outcomes of open abdominal treatment: long-term results of vacuum-assisted wound closure and mesh-mediated fascial traction (VAWCM).

Authors:  A Willms; S Schaaf; R Schwab; I Richardsen; C Jänig; D Bieler; B Wagner; C Güsgen
Journal:  Langenbecks Arch Surg       Date:  2017-04-05       Impact factor: 3.445

4.  High rate of incisional hernia observed after mass closure of burst abdomen.

Authors:  T K Jensen; I Gögenur; M-B Tolstrup
Journal:  Hernia       Date:  2021-10-21       Impact factor: 2.920

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.